Fam177a1 Research Fund is ranked among medical research organizations in Mercer Island, WA, with an America's Best Score of 62 out of 100, based on its 2025 Form 990.
The FAM177A1 Research Fund is a family-led patient advocacy organization dedicated to improving the lives of everyone impacted by FAM177A1 Disorder. We provide hope to affected families while focusing the global research community on FAM177A1 to develop life-transformative treatm
Largest programs · fiscal year 2025
Patient Advocacy & Data: Global Networking: Successfully connected with more families globally, including new cases in the Middle East and Europe, increasing the known patient cohort to facilitate research.$153,211 spent · 62.1% of program spending
Breakthrough Research & Grants: The Fund strategically allocated resources to multiple international research projects aimed at understanding the genes function and developing therapies: Gene Therapy Initiative: Funded a pioneering AAV9-based gene therapy project at Hebrew University led by Professor Rami I. Aqeilan, aiming to deliver functional copies of the FAM177A1 gene. CURE Epilepsy Partnersh… Read more
Breakthrough Research & Grants: The Fund strategically allocated resources to multiple international research projects aimed at understanding the genes function and developing therapies: Gene Therapy Initiative: Funded a pioneering AAV9-based gene therapy project at Hebrew University led by Professor Rami I. Aqeilan, aiming to deliver functional copies of the FAM177A1 gene. CURE Epilepsy Partnership: Formed a significant partnership with CURE Epilepsy to co-fund a $100,000 grant. This project, led by Dr. Berrak Ugur at Yale University, utilizes patient-derived organoids (brain-in-a-dish) to study how FAM177A1 loss affects neuronal growth and protein transport in the Golgi complex. Model Organism Development: Continued funding for research at the University of Portsmouth (UK) using Xenopus (frog) models to test potential treatments and study early brain development mysteries. Drug Repurposing: Advanced work on fruit fly models to identify existing medications that might be effective for FAM177A1 patients.
$93,601 spent · 37.9% of program spending
Fundraising & Awareness: The Organization saw a record-breaking year for community engagement: FAM JAM 2025: The 2nd annual FAM JAM event in Seattle raised $280,000, directly fueling the research pipeline. Impact Reporting: Released the 2024 Impact Report in March 2025, providing transparency and documenting the foundations growth and scientific strategy for donors.
Where each dollar went · fiscal year 2025
Of every dollar it spent, 91¢ went to programs, 1¢ to management and 8¢ to fundraising.
Programs $246,812
Management $2,689
Fundraising $22,723
In the organization's own words to the IRS, shown for context. None of this affects the America's Best Score, and a Form 990 describes programs without measuring their results.
Spending on programs Not scored; America's Best needs 65%+
91%
Meets
Tax filings by year
Financial data extracted from the Form 990 the organization filed with the IRS for each fiscal year. Revenue lines can exceed 100% when other items, such as fundraising event costs, are netted against total revenue.
Revenue$333,831Fiscal year 2025
Expenses$272,224Fiscal year 2025
Total assets$327,249Fiscal year 2025
Total liabilities$0Fiscal year 2025
Fiscal year ending December2025
Revenue$333,831
Expenses$272,224
Net income$61,607
Net assets$327,249
Notable sources of revenue
Percent of total revenue
Contributions
$362,115
108.5%
Program services
$0
0.0%
Investment income
$4,967
1.5%
Other (net)
−$33,251
−10.0%
Assets / debt
Total assets
$327,249
Total liabilities
$0
Net assets
$327,249
Compensation
Not in our extract for this year.
Fiscal year ending December2024
Revenue$306,239
Expenses$81,485
Net income$224,754
Net assets$265,642
Notable sources of revenue
Percent of total revenue
Contributions
$306,239
100.0%
Program services
$0
0.0%
Investment income
$0
0.0%
Other (net)
$0
0.0%
Assets / debt
Total assets
$265,642
Total liabilities
$0
Net assets
$265,642
Compensation
Not in our extract for this year.
Fiscal year ending December2023
Revenue$129,152
Expenses$102,871
Net income$26,281
Net assets$40,887
Notable sources of revenue
Percent of total revenue
Contributions
$102,004
79.0%
Program services
—
—
Investment income
—
—
Other (net)
$27,148
21.0%
Assets / debt
Total assets
—
Total liabilities
—
Net assets
$40,887
Compensation
Not in our extract for this year.
About this data
Figures come from IRS Form 990 filings, through the IRS Exempt Organizations Business Master File (2026-11-09) and e-filed returns. Form 990 data typically lags 12–24 months behind an organization's fiscal year. Found an error?